Wild-Type | Lys191 → Ala191 | Thr194 → Ala194 | |||||||
---|---|---|---|---|---|---|---|---|---|
k+13-a | k−13-b | t1/23-c | k+13-a | k−13-b | t1/23-c | k+13-a | k−13-b | t1/23-c | |
[3H]Mepyramine | 513 ± 186 | 0.86 ± 0.08 | 0.8 | 923 ± 204 | 1.10 ± 0.043-160 | 0.6 | 443 ± 40 | 0.21 ± 0.023-165 | 4 |
Levocetirizine | 2.3 ± 0.4 | 0.005 ± 0.002 | 142 | 5.9 ± 1.23-160 | 0.052 ± 0.0263-150 | 13 | 7.1 ± 1.83-160 | 0.007 ± 0.002 | 107 |
(S)-Cetirizine | 1.6 ± 0.7 | 0.12 ± 0.05 | 6 | 4.6 ± 1.43-150 | 0.69 ± 0.293-150 | 1.0 | 5.0 ± 1.33-160 | 0.030 ± 0.0133-150 | 24 |
(S)-Hydroxyzine | 25 ± 2 | 0.47 ± 0.15 | 1.5 | N.D. | N.D. | N.D. | 73 ± 52 | 0.15 ± 0.103-150 | 5 |
(R)-Hydroxyzine | 13 ± 2 | 0.022 ± 0.006 | 31 | 66 ± 213-150 | 0.042 ± 0.0083-150 | 17 | 66 ± 153-160 | 0.015 ± 0.004 | 47 |
(R)-ucb 29992 | 70 ± 12 | 0.097 ± 0.04 | 7 | 81 ± 9 | 0.070 ± 0.013 | 10 | 131 ± 41 | 0.088 ± 0.044 | 8 |
(S)-ucb 29993 | 83 ± 32 | 3.313 ± 2.01 | 0.2 | N.D. | N.D. | N.D. | 180 ± 166 | 0.87 ± 0.52 | 0.8 |
Terfenadine | 10 ± 5 | 0.019 ± 0.009 | 37 | 30 ± 113-150 | 0.054 ± 0.0243-150 | 13 | N.D. | N.D. | N.D. |
Fexofenadine | 1.2 ± 0.3 | 0.011 ± 0.004 | 62 | 2.2 ± 0.63-150 | 0.031 ± 0.0063-160 | 22 | N.D. | N.D. | N.D. |
Loratadine | 3.6 ± 0.6 | 0.13 ± 0.02 | 5 | 5.8 ± 0.23-150 | 0.045 ± 0.0133-150 | 15 | N.D. | N.D. | N.D. |
Results are the mean ± S.D. of three experiments. Data were analyzed according to the model proposed by Motulsky and Mahan (1984)as described under Materials and Methods. k −1 for [3H]mepyramine were measured directly in separate experiments and kept constant in the model.P values were obtained from two-tailed, unpaired Studentt tests comparing results from mutant receptors with those of wild-type receptors.